Asset Management One Co. Ltd. Has $38.79 Million Position in Colgate-Palmolive Company (NYSE:CL)

Asset Management One Co. Ltd. boosted its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 5.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 413,948 shares of the company's stock after acquiring an additional 21,010 shares during the quarter. Asset Management One Co. Ltd. owned 0.05% of Colgate-Palmolive worth $38,787,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of CL. Kohmann Bosshard Financial Services LLC acquired a new stake in Colgate-Palmolive in the 4th quarter valued at about $26,000. Vermillion Wealth Management Inc. acquired a new position in Colgate-Palmolive during the 4th quarter worth $31,000. Union Bancaire Privee UBP SA acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $32,000. Briaud Financial Planning Inc acquired a new position in Colgate-Palmolive in the fourth quarter valued at approximately $32,000. Finally, Wintrust Investments LLC purchased a new position in shares of Colgate-Palmolive during the fourth quarter worth about $33,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Stock Performance

CL stock traded down $0.38 during midday trading on Wednesday, hitting $87.80. 3,407,409 shares of the company traded hands, compared to its average volume of 5,318,758. The stock has a market capitalization of $71.15 billion, a price-to-earnings ratio of 24.80, a price-to-earnings-growth ratio of 4.71 and a beta of 0.38. The business has a 50 day simple moving average of $91.26 and a 200-day simple moving average of $90.69. Colgate-Palmolive Company has a twelve month low of $85.32 and a twelve month high of $109.30. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.92 billion. During the same period in the previous year, the business earned $0.86 EPS. The firm's revenue was down 3.0% on a year-over-year basis. As a group, equities research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 18th will be given a dividend of $0.52 per share. The ex-dividend date is Friday, July 18th. This represents a $2.08 annualized dividend and a yield of 2.37%. Colgate-Palmolive's dividend payout ratio (DPR) is 58.76%.

Colgate-Palmolive declared that its board has authorized a share buyback plan on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 6.8% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's leadership believes its stock is undervalued.

Analyst Upgrades and Downgrades

Several analysts have commented on the company. Wells Fargo & Company upped their price objective on Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a research note on Wednesday, April 2nd. Barclays decreased their price target on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a research note on Friday, April 11th. JPMorgan Chase & Co. increased their price target on Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a report on Monday, April 28th. Piper Sandler dropped their price objective on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a report on Monday, March 31st. Finally, UBS Group boosted their target price on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the company a "buy" rating in a research note on Thursday, April 17th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and nine have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $101.69.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.